The use of Artificial Intelligence (AI) is becoming increasingly prevalent in the medical field, and now, researchers at the University of California, Berkeley have used AI to discover a new path towards the development of safer senolytic compounds. Senolytic compounds are compounds that can be used to selectively kill senescent cells, which are cells that have stopped growing and dividing and can contribute to aging and age-related diseases. Using AI, the researchers were able to identify a set of compounds that were more likely to be safe for use in humans. This is a huge step forward in the development of senolytic compounds and the fight against age-related diseases.

Read Full Article Here

source: Phys.org